Several studies have shown the role of the alteration of VDR methylation in various neoplasms [144,145,146]; the study of Mai Abdalla [147] evaluated the methylation of the VDR promoter as a potential biomarker for the identification of HCC. Here, VDR is linked to neoplasm.